...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Creation of the 'thymoheart' allograft: implantation of autologous thymus into the heart prior to procurement.
【24h】

Creation of the 'thymoheart' allograft: implantation of autologous thymus into the heart prior to procurement.

机译:创建“胸腺”同种异体移植物:在采购前将自体胸腺植入心脏。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: A state of tolerance may be more easily achieved if fully vascularized and functional donor thymus is transferred to the recipient at the time of whole organ transplantation. METHODS: A composite "thymoheart" allograft was created by implanting autologous thymus into a donor heart 60-90 days before organ procurement. Successful intracardiac engraftment of autologous thymus was documented by histology and by flow cytometric analysis. RESULTS: Histology of the thymic autografts at explantation revealed viable thymus with preservation of normal thymic architecture. Cells retrieved from thymic autografts 60 days after implantation exhibited the same MHC class I and class II staining profiles by flow cytometry as cells taken from the residual native thymus. CONCLUSION: We have created a novel composite organ that confers vascularized and functional donor thymus to heart allograft recipients at the time of transplantation without affecting cardiac function.
机译:背景:如果在整个器官移植时将完全血管化和功能正常的供体胸腺转移至受体,则更容易达到耐受状态。方法:通过在器官采购前60-90天将自体胸腺植入供体心脏,创建复合“胸腺”同种异体移植物。通过组织学和流式细胞术分析证明自体胸腺成功植入心脏。结果:胸腺自体移植的组织学结果显示可行的胸腺并保留了正常的胸腺结构。植入后60天从胸腺自体移植中检索到的细胞与从残留的天然胸腺中提取的细胞相比,通过流式细胞术显示出相同的MHC I类和II类MHC染色曲线。结论:我们创建了一种新型复合器官,在移植时将具有血管功能的供体胸腺授予同种异体心脏移植受体,而不会影响心脏功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号